IFRX (InflaRx NV) E10: $-1.34 (As of Mar. 2026)


IFRX InflaRx NV IFRX
31 GF Score
Price $2.24
! 5 Warning Signs
View Full Analysis

What is InflaRx NV E10?

InflaRx NV IFRX -3.03% 31 E10 is $-1.34 as of Mar. 2026. GuruFocus rates IFRX with a GF Score™ of 31/100. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

InflaRx NV's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.092. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1.34 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-01), InflaRx NV's current stock price is $2.235. InflaRx NV's E10 for the quarter that ended in Mar. 2026 was $-1.34. InflaRx NV's Shiller PE Ratio of today is .


InflaRx NV  (NAS:IFRX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


InflaRx NV E10 Related Terms


InflaRx NV E10 Historical Data

* Premium members only.

The historical data trend for InflaRx NV's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InflaRx NV E10 Chart

InflaRx NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -1.35

InflaRx NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -1.35 -1.34

IFRX vs BCYC, ELDN, ZNTL: E10 Comparison

For the Biotechnology subindustry, InflaRx NV's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InflaRx NV Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InflaRx NV's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where InflaRx NV's Shiller PE Ratio falls into.


IFRX
31GF Score
InflaRx NV IFRX
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InflaRx NV E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, InflaRx NV's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.092/131.2583*131.2583
=-0.092

Current CPI (Mar. 2026) = 131.2583.

InflaRx NV Quarterly Data

per share eps CPI Adj_EPS
201606 -0.051 100.717 -0.066
201609 -0.103 101.017 -0.134
201612 -0.196 101.217 -0.254
201703 -0.174 101.417 -0.225
201706 -0.224 102.117 -0.288
201709 -0.207 102.717 -0.265
201712 -0.582 102.617 -0.744
201803 -0.530 102.917 -0.676
201806 -0.117 104.017 -0.148
201809 -0.303 104.718 -0.380
201812 -0.455 104.217 -0.573
201903 -0.429 104.217 -0.540
201906 -0.667 105.718 -0.828
201909 -0.617 106.018 -0.764
201912 -0.578 105.818 -0.717
202003 -0.354 105.718 -0.440
202006 -0.428 106.618 -0.527
202009 -0.294 105.818 -0.365
202012 -0.389 105.518 -0.484
202103 -0.214 107.518 -0.261
202106 -0.398 108.486 -0.482
202109 -0.318 109.435 -0.381
202112 -0.328 110.384 -0.390
202203 -0.352 113.968 -0.405
202206 0.011 115.760 0.012
202209 -0.178 118.818 -0.197
202212 -0.191 119.345 -0.210
202303 -0.268 122.402 -0.287
202306 -0.152 123.140 -0.162
202309 -0.139 124.195 -0.147
202312 -0.305 123.773 -0.323
202403 -0.185 125.038 -0.194
202406 -0.258 125.882 -0.269
202409 -0.333 126.198 -0.346
202412 -0.084 127.041 -0.087
202503 -0.141 127.779 -0.145
202506 -0.242 128.412 -0.247
202509 -0.211 129.255 -0.214
202512 -0.176 129.361 -0.179
202603 -0.092 131.258 -0.092

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-1.34 mean?
InflaRx NV (IFRX) has a E10 of $-1.34 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on InflaRx NV and its competitors.
Is InflaRx NV's E10 too high?
InflaRx NV's current E10 is $-1.34. Overall, InflaRx NV has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does InflaRx NV's E10 compare to BCYC and ELDN?
InflaRx NV's E10 of $-1.34 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on InflaRx NV and its competitors. InflaRx NV's current E10 is $-1.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InflaRx NV stock overvalued right now?
InflaRx NV (IFRX) has a current E10 of $-1.34. The current E10 is $-1.34. InflaRx NV's overall GF Score™ is 31/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For InflaRx NV (IFRX), the current E10 is $-1.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

InflaRx NV Business Description

Other Exchanges IF0:Germany
Address Winzerlaer Strasse 2, Jena, DEU, 07745
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
31GF Score

Get the complete analysis for IFRX

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.24
Price